Latest Market Research Report 2025

  The global   cell therapy market   was valued at USD 4.74 billion in 2023 and is projected to expand at a robust compound annual growth rate (CAGR) of 22.66% between 2024 and 2030. This rapid rate of expansion is driven in part by the continuous diversification of cell types being explored and commercialized, offering companies fresh avenues to consolidate and enhance their positions within this competitive landscape. Over the past several years, the sector has witnessed a substantial uptick in the number of organizations actively engaged in the research, development, and commercialization of novel cell-based treatments. A key catalyst behind this proliferation of market entrants is the significant increase in funding earmarked for clinical studies of cell therapies. Coupled with the establishment and widespread adoption of standardized guidelines for the manufacturing of cell-based products, these financial and regulatory enablers have lowered the barriers to entry and...

Cell Therapy Industry Overview The global cell therapy market size was valued at USD 7.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 14.5% from 2021 to 2028.    The market is majorly driven by the rising number of clinical studies for cell-based therapies. This has resulted in a substantial global investment in research and their clinical translation. The increasing number of ongoing clinical trials can be attributed to the presence of government and private funding agencies that are constantly offering grants to support projects across various stages of clinical trials.   Gather more insights about the market drivers, restrains and growth of the Global Cell Therapy Market   In addition, the field of regenerative medicine is witnessing series of advancements, further expected to offer effective treatment solutions for chronic ailments. Several companies in the growing markets, such as Canada, are at ...